🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Baird raises Axon shares target on AI growth prospects

EditorNatashya Angelica
Published 12/06/2024, 07:43 AM
AXON
-

On Friday, Baird, an investment firm, increased its stock price target for Axon Enterprise (NASDAQ:AXON), a company specializing in law enforcement technology, to $800 from the previous target of $600.

The firm has reiterated its Outperform rating for Axon's shares. The stock has demonstrated remarkable momentum, with a 167% year-to-date return and currently trades near its 52-week high of $695.94. According to InvestingPro analysis, the stock is currently trading close to its Fair Value.

The revision follows a recent visit by Baird analysts to Axon's headquarters, where they witnessed product demonstrations and engaged with the company's management team. The analysts have expressed confidence in Axon's growth trajectory, particularly highlighting the potential of artificial intelligence (AI) within the company's operations.

The confidence appears well-founded, as InvestingPro data shows impressive revenue growth of 32.3% and strong financial health metrics. InvestingPro subscribers have access to 23 additional insights about Axon's growth potential and financial strength.

Axon's focus on AI was evident during the visit, and the company has already reported early successes with its AI Era Plan, which was announced not long ago. The Baird analyst noted that while the enterprise and drone segments are still in the early stages, they present significant opportunities to expand the total addressable market (TAM).

Despite Axon's strong year-to-date performance in the stock market, Baird anticipates that the momentum driven by AI and software advancements will continue to bolster the company's stock value. This optimism has led to the increased price target, reflecting Baird's positive outlook on Axon's future in the evolving tech landscape.

In other recent news, Axon Enterprise demonstrated a robust financial performance with a reported revenue growth of 32.32% over the past year and a promising third-quarter performance.

The company's earnings have been revised upward by 13 analysts, reflecting confidence in its growth sustainability. Morgan Stanley (NYSE:MS), acknowledging this growth, upgraded Axon's stock from Equalweight to Overweight and increased the price target to $700.

Axon's positive outlook is attributed to robust police tech budgets and the company's competitive edge in AI solutions. The company's strong financial position, boasting impressive gross profit margins of 59.75% and more cash than debt, also contributes to its market position.

Axon's Q3 results were bolstered by its focus on artificial intelligence and TASER products, leading to record bookings and a 32% year-over-year growth in revenue. The company raised its Q4 revenue guidance to between $560-570 million and expects full-year revenue to exceed $2.07 billion.

In contrast, defense shares, including Axon, experienced a decline following potential ceasefire reports between Israel and Hezbollah. These recent developments indicate the dynamic nature of the market and underline the importance of independent research and consultation with a financial advisor.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.